MAY - JUNE 20186A hallmark in the cardiovascular devices landscape has been the growth of the global cardiovascular devices market at an exponential rate. This has occurred due to an amalgam of increasing awareness of the population, high preference of minimally invasive procedures over conventional surgeries, rapid technological advances, and emerging economies. What has made this exponential growth mushroom are the large number of mergers and acquisitions between cardiovascular devices manufacturing companies and in turn increasing novel product launches. Although, organizations have been smitten by this large-scale mega-institutioning of the cardiovascular devices landscape, they have been plagued by the challenge of skilled professionals to operate the devices and a high cost of the devices & their maintenance.Further, Innovations such as minimally invasive procedures, "beating heart" surgeries, ventricular assist devices and artificial hearts, replacement valves and treatments for hypertension such as renal denervation offer therapeutic options that result in shorter recovery times and reduced complication risks has substantiated the growth of cardiovascular devices space. Although, the global market for cardiovascular devices reached nearly $42.4 billion in 2017 and is subjected to churn $59.1 billion by 2022 at a CAGR of 6.9% for the period of 2017-2022, the problem remains as to how to leverage trends and build a strong business case in this sector.Curating content for this edition has been a dive into exploring a plethora of service providers, changing trends, needs of the hour and a glimpse into how the world of cardiovascular devices would turn out to be. We hope the valuable insights from industry thought-leaders and the innovative solutions from leading as well as emerging companies featured in this edition will help you in making informed decisions in your cardiovascular devices endeavors in 2018.Copyright © 2018 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MAY - JUNE - 2018VOLUME 01 - 03 CARDIO VASCULAR DEVICES SPECIALContact UsPhone:510 230 0396 Fax:510-894-8405Emailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comManaging EditorAlex D'souzaEditorial StaffSalesJoe Philip Laura PintoMatthew JacobMerlin WatsonSarah FernandesSpurthi PatilVisualizerIssac GeorgeEric Thomaseric@medicaltechoutlook.com510.722.8394Alex D'souzaManaging Editoreditor@Medicaltechoutlook.comThe Business Case of Cardiovascular Device Landscape*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditorialPublished by ValleyMedia Inc. To subscribe to MedicalTech OutlookVisit www.Medicaltechoutlook.com
< Page 5 | Page 7 >